2001
Tamoxifen and Cardiac Risk Factors in Healthy Women
Cushman M, Costantino J, Tracy R, Song K, Buckley L, Roberts J, Krag D. Tamoxifen and Cardiac Risk Factors in Healthy Women. Arteriosclerosis Thrombosis And Vascular Biology 2001, 21: 255-261. PMID: 11156862, DOI: 10.1161/01.atv.21.2.255.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAnti-Inflammatory AgentsAntineoplastic Agents, HormonalBlood CoagulationBreast NeoplasmsC-Reactive ProteinCardiovascular DiseasesCardiovascular SystemCholesterolDouble-Blind MethodFemaleFibrinogenHumansPlacebosPostmenopauseRisk FactorsSelective Estrogen Receptor ModulatorsTamoxifenConceptsEffects of tamoxifenBreast Cancer Prevention TrialIncidence of breast cancerCardiovascular disease risk factorsHigh waist-to-hip ratioWaist-to-hip ratioHealthy womenDisease risk factorsRisk factorsCancer Prevention TrialAssociated with venous thrombosisFactor VII coagulant activityAssociation of tamoxifenFactors related to inflammationEffects of oral tamoxifenCardiac risk factorsC-reactive proteinVII coagulant activitySecondary analysisPrevention trialsMedian fibrinogenOral tamoxifenPostmenopausal womenPostmenopausal estrogenVenous thrombosis
1997
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
Bluhm G, Sharp J, Tilley B, Alarcon G, Cooper S, Pillemer S, Clegg D, Heyse S, Trentham D, Neuner R, Kaplan D, Leisen J, Buckley L, Duncan H, Tuttleman M, Li S, Fowler S. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. The Journal Of Rheumatology 1997, 24: 1295-302. PMID: 9228128.Peer-Reviewed Original ResearchConceptsJoint space narrowingRheumatoid arthritis trialsDisease progressionArthritis trialsSpace narrowingPercentage of patientsSignificant differencesReported clinical resultsErosive jointsOral minocyclinePlacebo groupErosive diseaseFinal visitRadiographic progressionPlacebo treatmentTreat analysisRadiographic resultsFuture trialsClinical centersClinical resultsPosteroanterior filmsRadiographic changesTreatment benefitProgression rateWeek trial
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply